During the last session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 0.4 million, with the beta value of the company hitting 2.17. At the end of the trading day, the stock’s price was $0.27, reflecting an intraday gain of 5.02% or $0.01. The 52-week high for the PTPI share is $2.27, that puts it down -740.74 from that peak though still a striking 18.52% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $2.70M, and the average intraday trading volume over the past 10 days was 0.21 million shares, and the average trade volume was 176.68K shares over the past three months.
Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information
Petros Pharmaceuticals Inc (PTPI) registered a 5.02% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.02% in intraday trading to $0.27, hitting a weekly high. The stock’s 5-day price performance is 4.21%, and it has moved by -25.24% in 30 days. Based on these gigs, the overall price performance for the year is -78.75%. The short interest in Petros Pharmaceuticals Inc (NASDAQ:PTPI) is 0.2 million shares and it means that shorts have 0.72 day(s) to cover.
Petros Pharmaceuticals Inc (PTPI) estimates and forecasts
In the rating firms’ projections, revenue will decrease -6.67% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.28M as predicted by 1 analyst(s).
While earnings are projected to return 67.43% in 2024.
PTPI Dividends
Petros Pharmaceuticals Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders
Petros Pharmaceuticals Inc insiders own 8.10% of total outstanding shares while institutional holders control 2.29%, with the float percentage being 2.49%.
Also, the Mutual Funds coming in first place with the largest holdings of Petros Pharmaceuticals Inc (PTPI) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 35.68 shares. This amounts to just over 0.36 percent of the company’s overall shares, with a $9630.0 market value. The same data shows that the other fund manager holds slightly less at 31.81, or about 0.32% of the stock, which is worth about $8585.0.
